Archives
FDA Approves Sanofi's Cerdelga for Gaucher Disease Type 1
The U.S Food and Drug Administration announced Tuesday that it has approved Sanofi's Cerdelga (eliglustat) to treat Type 1 form of Gaucher disease.
Latest Research Articles
Nepal's Killer Floods Will Return Soon, Experts Warn
Child Drawings Can Help Predict Intelligence
The Birth of Pathogens: How Bacteria Become Deadly
Rosetta's 'Rubber Ducky' Comet Compared to Los Angeles
Long Lost Carolina Wolf Spider Found in Ohio
Rarest Dragonfly Saved by Speed Limits?
You Just Experienced One of the Warmest Julys Ever
Manatee Drowns in Paris Zoo
Solar Cells Recycled from Old Car Batteries
Curiosity Rover Skids Away from Unexpected Sand Trap
Rabbit Meat for Sale at Whole Foods, Causes Outrage
Slight Ice Sheet Fluctuations May Cause Abrupt Climate Change
MOST POPULAR
-
3I/ATLAS Update: What Did ExoMars Trace Gas Orbiter Capture at Close Range Before Comet Disappeared Behind the Sun?
-
Hurricane Melissa Targets Southeast Bahamas and Bermuda After Historic Category 5 Jamaica Landfall
-
Microplastics Health Effects: Are Environmental Toxins and Plastic in the Bloodstream Dangerous?
-
7 Climate Change Animals Showing Incredible Species Adaptation and Thriving in a Warming World
-
10 Fascinating Ways Trees Communicate Underground Through Mycorrhizal Networks
